Proteolysis of the low density lipoprotein receptor by bone morphogenetic protein-1 regulates cellular cholesterol uptake

Autor: Daniel S. Greenspan, Kate Fisher, Sreemoti Banerjee, Catherine B. Lawrence, Carolyn D. Jackson, Katherine A. B. Kellett, Christopher J. Duff, Nobuyo Maeda, Nigel M. Hooper, Robert J. Andrew
Rok vydání: 2018
Předmět:
0301 basic medicine
Biopsy
lcsh:Medicine
Q1
Bone Morphogenetic Protein 1
chemistry.chemical_compound
Mice
0302 clinical medicine
RNA
Small Interfering

Receptor
lcsh:Science
Metalloproteinase
Oxadiazoles
Multidisciplinary
medicine.diagnostic_test
Chemistry
Hep G2 Cells
Recombinant Proteins
3. Good health
Cell biology
Lipoproteins
LDL

Mechanisms of disease
Manchester Institute for Collaborative Research on Ageing
Liver
Gene Knockdown Techniques
lipids (amino acids
peptides
and proteins)

ResearchInstitutes_Networks_Beacons/MICRA
Proteolysis
Mice
Transgenic

CHO Cells
Bone morphogenetic protein 1
Article
03 medical and health sciences
Cricetulus
Extracellular
medicine
Animals
Humans
Author Correction
Dyslipidaemias
Cholesterol
lcsh:R
Atherosclerosis
R1
030104 developmental biology
Receptors
LDL

LDL receptor
lcsh:Q
030217 neurology & neurosurgery
Lipoprotein
Zdroj: Scientific Reports
Banerjee, S, Andrew, R J, Duff, C J, Fisher, K, Jackson, C D, Lawrence, C B, Maeda, N, Greenspan, D S, Kellett, K & Hooper, N 2019, ' Proteolysis of the low density lipoprotein receptor by bone morphogenetic protein-1 regulates cellular cholesterol uptake ', Scientific Reports . https://doi.org/10.1038/s41598-019-47814-0
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
ISSN: 2045-2322
Popis: The development of cardiovascular disease is intimately linked to elevated levels of low-density lipoprotein (LDL) cholesterol in the blood. Hepatic LDL receptor (LDLR) levels regulate the amount of plasma LDL. We identified the secreted zinc metalloproteinase, bone morphogenetic protein 1 (BMP1), as responsible for the cleavage of human LDLR within its extracellular ligand-binding repeats at Gly171↓Asp172. The resulting 120 kDa membrane-bound C-terminal fragment (CTF) of LDLR had reduced capacity to bind LDL and when expressed in LDLR null cells had compromised LDL uptake as compared to the full length receptor. Pharmacological inhibition of BMP1 or siRNA-mediated knockdown prevented the generation of the 120 kDa CTF and resulted in an increase in LDL uptake into cells. The 120 kDa CTF was detected in the livers from humans and mice expressing human LDLR. Collectively, these results identify that BMP1 regulates cellular LDL uptake and may provide a target to modulate plasma LDL cholesterol.
Databáze: OpenAIRE